Clinical Trial Update: Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 trial update on BRAINMAX® therapy using fMRI for asthenia after COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthenia
• Cognitive Impairment

Drugs mentioned

• BRAINMAX®

Snippet

Sponsor: Promomed, LLC | Conditions: Asthenia, COVID-19 | Phase 4 | Status: COMPLETED